Clinical Trial Update: Warfarin Versus Aspirin in Patients With Atrial Fibrillation and Chronic Kidney Disease [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial comparing warfarin versus aspirin in patients with atrial fibrillation and chronic kidney disease has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Chronic Kidney Disease

Drugs mentioned

• Aspirin (Aspirin)
• Warfarin (warfarin)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Atrial Fibrillation, Chronic Kidney Disease | Phase 4 | Status: WITHDRAWN